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Abstract.  Lysosomes constitute only 4%  of the intra- 
cellular volume of a normal human fibroblast. When 
human fibroblasts are incubated for 2-5  min with 20 
t~M [asS]cystine in Krebs-Ringer phosphate solution at 
pH 7.4,  a minimum of 50-60%  of the total radioactiv- 
ity taken up by the cells is found sequestered into the 
lysosomal compartment in the form of cysteine. A 
lysosomal transport system, highly specific for cys- 
teine, appears to facilitate this rapid lysosomal cysteine 
sequestration. Time courses of [35S]cysteine uptake into 
isolated, Percoll-purified fibroblast lysosomes at pH 
7.0 and 37°C are linear for the first 4-5 min and attain 
a steady state by  10 min. Lysosomal cysteine uptake 
displays a Km of 0.05 mM at pH 7.0 and an activation 
energy of 21  kcal/mol, corresponding to a Qt0 of 3.2. 
The role of this transport system in delivering cysteine 
into lysosomes is supported by its pH curve showing a 
slow rate of cysteine transport at the acidic pHs be- 
tween 5 and 6, but then increasing sevenfold between 
pH 6 and 7.5 to be maximally active near the cytosolic 
pH of 7.  Carrier mediation by this lysosomal transport 
route demonstrates a high specificity for cysteine as in- 
dicated by the inability of the following amino acids to 
significantly inhibit at 5 mM the lysosomal uptake of 
0.035  mM [3sS]e-cysteine: ala,  ser, pro, val, gly, 
homocysteine, D- or e-penicillamine, arg, asp, or leu. 
Similarly, D-cysteine and 3-mercaptopropionate were 
poor inhibitors, suggesting that both the L-isomer and 
a-amino group of cysteine appear to be required for 
recognition by the cysteine-specific transport system. 
In contrast, cysteamine, which lacks an a-carboxyl 
group, was able to strongly inhibit lysosomal cysteine 
uptake. The physiological importance of this cysteine- 
specific lysosomal transport system may be to aid 
lysosomal proteolysis by delivering cysteine into the 
lysosomal compartment to (a) maintain the catalytic 
activity of the thiol-dependent lysosomal enzymes and 
(b) break protein disulfide bridges at susceptible link- 
ages, thereby allowing proteins to unfold, facilitating 
their degradation. 
VSOSOMES are a major intracellular site for the degrada- 
tion of a wide variety of macromolecules which are 
delivered to this organelle by receptor-mediated en- 
docytosis, pinocytosis,  or autophagy. Many of the metabo- 
lites formed in the lysosome as a consequence of the break- 
down of macromolecules appear to egress from the lyso- 
somal compartment by way of carrier-mediated transport 
systems.  Specific lysosomal  transport systems for cystine 
(13-15, 19), the cationic amino acids (29, 31), small neutral 
amino acids (30), large neutral amino acids (6, 47), nucleo- 
sides (28), acidic monosaccharides (24, 32), and the sugars 
N-acetyl galactosamine and N-acetyl glucosamine (20) have 
been described.  The  importance of transport  systems  in 
mediating the escape of metabolites from the lysosomal com- 
partment becomes especially  obvious in the lethal genetic 
disease,  nephropathic  cystinosis. In this disorder,  defective 
A preliminary report of this work has appeared in abstract form (Pisoni, 
R.  L., T. L.  Acker, and J.  G. Thoene.  1989.  Pediatr.  Res.  25:144A). 
lysosomal cystine transport results in the lysosomal accumu- 
lation of cystine causing cystine crystals to form in various 
body tissues, with renal glomerular failure occurring by ten 
years of age (16). The lysosomal accumulations observed in 
two other inherited disorders,  Salla disease and one form of 
methylmalonic  aciduria,  have been attributed  to  impaired 
lysosomal transport of sialic acid and cobatamin, respec- 
tively (32, 35). 
In the present work we describe a lysosomal transport sys- 
tem highly specific for the amino acid cysteine. In contrast 
to many of the previously characterized lysosomal transport 
systems, this system appears to function for net delivery of 
its substrate into the lysosomal compartment rather than to 
serve for exodus of the products  of lysosomal hydrolysis. 
This cysteine-specific transport route may play an important 
role in supporting lysosomal proteolysis by providing thiol 
for the lysosomal thiol-dependent proteases and by reducing 
protein disulfide bridges,  thereby allowing proteins  to un- 
fold, facilitating their degradation. 
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Cell Culture 
Normal (GMOOIOA) and cystinotic (GM0090A) human fetal fibroblast cell 
lines were obtained from the Human Genetic Mutant Cell Repository (Cam- 
den, N  J). Fihroblasts were grown and maintained in an atmosphere of 95% 
air, 5% CO2 in 100-ram  tissue culture dishes or 850-cm  2 roller bottles in 
Coon's modification of Ham's F-12 medium (Gibco Laboratories, Grand Is- 
land, NY) supplemented with 10% FBS (44). Human fibroblasts were rou- 
tinely split 1:4 during passage and were not used beyond passage 22. 
F~S]Cystine Uptakes into Intact 
Human l~broblasts 
Cell culture medium was discarded from confluent 100-ram plates of fibro- 
blasts, monolayers were washed twice with 10-ml portions of warm PBS, 
and fibroblasts were then incubated with 3 ml of a 0.02-raM [35S]cystine 
solution (~2  x  107 cpm/plate) in sodium-containing Krebs-Ringer phos- 
phate buffer, pH 7.4,  supplemented with 0.1%  glucose (8).  The culture 
plates were gently rocked and, at the indicated times, incubations were ter- 
minated  by  aspirating  the  radioactive  medium  and  washing  the  cell 
monolayers three times with 10-ml portions of ice-cold PBS. Cells were 
then scraped into 4 ml of ice-cold PBS containing 10 mM N-ethylmaleimide 
(NEM) l and collected by centrifugation at 750 g for 1.5 rain at 4"C. Cell 
pellets were resuspended in 10 ml of 20-raM 3-(N-morpholino)propanesul- 
fonic acid (MOPS)/Tris (pH 7.0) buffer containing 0.275 M mannitol and 
10 mM NEM and centrifuged at 750 g for 1.5 min at 4°C. The supernatant 
was  discarded  and  the  cell  pellet  resuspended  in  3.5  ml  of  10  mM 
MOPS/Tris (pH 7.6) buffer containing 0.25  M sucrose, 1 mM Na2EDTA, 
and 10 mM NEM (lysis buffer). Cells were then lysed by up and down pipet- 
ting of the suspension 12 times as described previously (18, 29), and cen- 
trifuged at 750 g for 2.5 min at 4"C. The supernatants from three eunsecu- 
tive rounds of cell lysis were pooled and centrifuged at 1,500 g for 10 min 
at 4"C to remove nuclei. The resulting postuuclear supernatant, which con- 
tained >90% of the total radioactivity recovered from the cells, was cen- 
trifuged at 20,000 g for 15 min at 4°C in a rotor (SS-34; Sorvall Instruments 
Div., Newton, CT). Aliquots of the 20,000 g supernntant were assayed for 
radioactivity and hexosaminidase activity,  whereas the 20,000  g  pellet, 
which constitutes the granular fraction, was resuspended to 0.35 ml with 
the lysis buffer and aliquots counted for radioactivity and hexosaminidase 
activity. 
The nature of the acid-soluble, intracellular radioactivity resulting from 
[35S]cystine uptakes into intact fibroblasts was determined by adding 1/10 
vol of  40% sulfosalicylic acid to the fraction, removing the precipitated pro- 
teins by centrifugation in an Eppendorf  microcentrifuge (Brinkmarm Instru- 
ments, Westbury, NY) for 7 min at 4"C, and then subjecting the acid-soluble 
supernatant to either high voltage etectrophoresis in 6% formic acid for 35 
min at 3,500 V (44) or descending paper chromatography overnight in a sol- 
vent of n-butanol/acetic acid/H20 (45:5:12.5).  30 nmol each of cystine, 
cysteine-NEM, and glutathione-NEM were included as internal standards 
with samples and were visualized with a ninhydrin spray. Sample lanes were 
then cut into segments of 1-2 cm in width and counted in 10 ml of Cytoscint 
scintillation fluid (ICN K & K Laboratories, Plainview,  NY) to measure ra- 
dioactivity. 
[14C]Alanine uptakes were performed as described for cystine uptakes, 
except that 2 mM aminooxyacetic acid was included in the incubation mix- 
tures to inhibit transamination of alanine to pyrnvate (10). 
Preparation of  PercoU-Purified Fibroblast Lysosomes 
Fibroblast lysosomes were purified on Percoll density gradients as de- 
scribed  previously  (30),  and  were  generally  resuspended  in  40  mM 
MOPS/Tris, (pH 7.0) buffer containing 0.25 M sucrose for use in most of 
the transport studies. Typically,  2--4 confluent roller bottles of fibroblasts 
were required per experiment to provide sufficient quantities of lysosomes 
for accurate measurement of lysosomal cysteine transport activity.  The in- 
tegrity  of individual  lysosomal preparations was generally found to be 
80--90%  intact as judged by the latency of/3-N-acetylhexosaminidase  activ- 
ity, which was calculated as the difference in hexosaminidase activity in the 
presence or absence of  0.1% Triton. B-N-Acetylhexosaminidase  activity was 
measured as described previously (28). 
1.  Abbreviations  used in  this paper:  GSH,  reduced glutathione; NEM, 
N-ethylmaleimide. 
Lysosomal Cysteine Uptake Studies 
Time courses at 37°C were initiated by mixing a prewarmed 200-t~l aliquot 
of 0.108 mM [35S]cysteine in 0.25 M sucrose containing 2 mM DTT with 
a 200-#1 aliquot of lysosomes suspended in 40 mM MOPS/Tris (pH 7.0) 
buffer containing 0.25 M sucrose. At the indicated times, 26.5-~1 aliquots 
were removed from the incubation mixture, added to 12 ml of ice-cold PBS, 
and filtered through a GF/A glass fiber filter (Whatman Inc., Clifton, NJ; 
24 mm); the filter was washed twice with 12-ml portions of ice-cold PBS 
and then counted for radioactivity in 10 ml of Cytoscint scintillation fluid. 
Blanks for each experiment consisted of substituting 40 mM MOPS/Tris 
(pH 7.0) buffer containing 0.25 M sucrose for the lysosomes in the incuba- 
tion mixtures. Aliquots removed from the blank incubations were filtered 
and washed in the same manner as for samples containing lysosomes. Ra- 
dioactivity retained an the GF/A filters for these blank mixtures was sub- 
tracted from radioactivity retained on filters of lysosome-containing sam- 
ples. 90%  of the radioactivity taken up by fibroblast lysosomes during a 
2.5-min incubation could be released from the lysosomes by exposing the 
lysosomal suspension to 0.1% Triton. In addition, uptakes were diminished 
60% by increasing the osmolarity of the uptake incubation mixtures three- 
fold. No significant metabolism of the [35S]cysteine taken up by the lyso- 
somes was observed as judged by high voltage electrophoresis. 
For the Km experiments, a 12-/~1 aliquot of 0.003 mM [35S]cysteine in 10 
mM MOPS/Tris (pH 7.0) buffer containing 0.25 M sucrose and 3 mM DTT 
was mixed with a  12-td aliquot of unlabeled cysteine solutions of varying 
concentration in 40 mM MOPS/Tris (pH 7.0) buffer containing 0.25 M su- 
crose and DTT,  with the DTT concentration being twice that of the unla- 
beled cysteine concentration. The tubes were warmed to 37°C and at time 
zero a 12-/~1  aliquot of ice-cold lysosomal suspension in 40 mM MOPS/Tris 
(pH 7.0) buffer containing 0.25 M sucrose was added to individual tubes and 
the mixtures incubated for 2.5 rain at 37°C; a 27-#1 aliquot was then re- 
moved from each incubation mixture, added to 12 ml of ice-cold PBS, lyso- 
somes were collected on a GF/A glass fiber filter, washed, and counted for 
radioactivity as described above.  The kinetic constants, Km and Vmx, and 
the nonsaturable component of uptake were calculated using the TOORGL 
program of Cleland (9) which applies the Gauss-Newton nonlinear least 
squares  method  in  fitting  the  initial  rate  kinetic data  to  the  following 
equation:  (voxs  ) 
log v  =  log \  Km  +  S  +  Kd'S 
Analog inhibition experiments were performed in a manner similar to the 
Km experiments except that the unlabeled cysteine substrate solution was 
replaced by an analog inhibitor solution containing DTT  of a  threefold 
greater molar concentration than the analog concentration. 
Miscellaneous 
[35S]Cystine  (400-500 Ci/mmol,  I  mCi/ml) was obtained from DuPont- 
NEN (Wilmington, DE) and was purified before use by diluting its specific 
activity to 80 Ci/mmol by the addition of unlabeled eystine, absorbing 
250-500/~Ci of radioactivity to 0.2-0.4 ml of Dowex 50W-X8  cation ex- 
change resin (Bio-Rad Laboratories, Richmond, CA) in water, washing the 
resin five times with 10-ml portions of deionized water, and then eluting 
[35S]cystine from the resin with 3 ml of 2 M NI-14OH. The eluted radioac- 
tivity was filtered through a 0.22-/zm filter unit (Spin-X; Costar, Data Pack- 
aging Corp., Cambridge, MA), dried under nitrogen, and redissolved in 0.5 
ml of distilled water for use. Radioactivity prepared in this manner migrated 
as a single spot with a cystine standard both by high voltage electrophoresis 
and paper chromatography. [35S]Cysteine was prepared from the purified 
[35S]cystine by the addition of DTT as indicated in the various experiments. 
Percoll was purchased from Pharmacia LKB Biotechnology Inc. (Piscata- 
way, NJ), FBS was from Gibco Laboratories, N-ethylmaleimide was from 
Calbiochem-Behring Corp.  (San Diego, CA), and amino acids were ob- 
tained from Sigma Chemical Co. (St. Louis, MO). 
Results 
When intact normal human fibroblasts are incubated at 37°C 
with 0.02 mM [35S]cystine for short intervals ranging from 
2 to 5 min, the total acid-soluble radioactivity present in the 
cells is recovered mainly as cysteine with minor amounts of 
cystine  also  being  observed  (data  not  shown).  Previous 
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tine within the fibroblast is due to reduction of cystine by the 
high concentrations of reduced glutathione (GSI-I) present in 
the cytosol (27, 46). We examined if any of the radioactivity 
derived from the [35S]cystine taken up by normal human fi- 
broblasts during these short incubations is associated with 
lysosomes. Intact fibroblasts were incubated for 2 or 5 min 
with 0.02 mM [35S]L-cystine at pH 7.4, cells were harvested 
and then subjected to subcellular fractionation in the pres- 
ence of 10 mM NEM. The results shown in Table I indicate 
that ~50-60% of the total cystine radioactivity taken up by 
the fibroblasts was associated with the granular pellet; 99% 
of this radioactivity sequestered into the granular pellet was 
recovered as cysteine (Fig.  1). 
When the granular pellet from the ['S]cystine uptake ex- 
periments was fractionated on Percoll density gradients, the 
radioactivity associated  with  the  granular  pellet was  dis- 
tributed throughout the gradient in close correlation to the 
distribution of the lysosomal marker enzyme, ~N-acetyl- 
hexosaminidase (Fig. 2). Whereas mitochondria, Golgi vesi- 
cles, plasma membrane vesicles, and ER are known to sedi- 
ment  near  the  top  of these  Percoll  gradients,  the  great 
majority of the radioactivity was localized to the bottom one- 
third of the Percoll gradient in which only densely sediment- 
ing lysosomes are found (33).  The association of this ra- 
dioactivity with  lysosomes was  further confirmed by the 
observation that  when  lysosomes  were  specifically made 
buoyant by preloading them with amino acid methyl esters 
(41) the lysosomal mai'ker enzymes and radioactivity both 
shifted to the top of the Percoll gradient in a proportionate 
manner  (data  not  shown).  These results  indicate that  al- 
though lysosomes comprise only 4% of the intracellular vol- 
ume  of  normal  human  fibroblasts  (11), they  sequester 
50--60%  of the total [35S]cystine radioactivity taken up by 
intact fibroblasts during 2-5-min incubations. This radioac- 
tivity sequestered into fibroblast lysosomes is in the form of 
cysteine. A  very similar sequestration of radioactivity into 
the granular pellet was obtained when cystine uptakes were 
performed  with  cystinotic  fibroblasts  (data  not  shown). 
Based on the relative amounts of hexosaminidase activity in 
the 20,000 g supernatant and 20,000 g pellet (granular frac- 
tion), we estimate that ,~,20 % of the lysosomes are broken 
during the subcellular fractionation steps leading to the prep- 
aration of  the granular pellet. Thus, if no lysosomes had been 
broken in obtaining the granular fraction, we would expect 
to see 62-75 % of the total [35S]cystine-derived  radioactivity 
taken up by the fibroblasts to be located in lysosomes. 
Table L Distribution of Radioactivity in Various Fibroblast Cell 
of O. 02 mM [35S]Cystine or O. 02 mM [t4C]Alanine 
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Figure 1. High voltage electrophoresis of the acid-soluble radioac- 
tivity present within the granular fraction of normal human fibro- 
blasts following the uptake of 20 #M [35S]cystine. Normal human 
fibroblasts were incubated with 20  #M  [35S]cysteine in  Krebs- 
Ringer (pH 7.4) buffer at 37°C for 5 min; the cells were then washed 
three times with ice-cold PBS, lysed, and a granular fraction pre- 
pared as described in Materials and Methods. Proteins in the granu- 
lax fraction were precipitated by the addition of sulfosalicylic acid, 
and an aliquot of the resulting acid-soluble radioactivity was sub- 
jected to high voltage electrophoresis as described in Materials and 
Methods.  The position  of the  internal  standards cystine,  cys- 
teine-NEM, and glutathione-NEM,  relative to the distribution of 
radioactivity is shown. 
Cystine is transported across the plasma membrane of hu- 
man fibroblasts by the X-ca transport system (2-5).  Sub- 
strates for the X-ca transport system at concentrations of 10 
mM strongly inhibited the uptake of [35S]cystine into fibro- 
blasts resulting in a large decrease in the amount of radioac- 
tivity associated with the granular pellet (Fig. 3). In contrast, 
amino acids which are either not recognized or only weakly 
recognized by the X-ca transport system, had little effect on 
the amount of  radioactivity sequestered into the granular pel- 
let when these amino acids were added to the [35S]cystine 
uptake mixtures. Therefore, the radioactivity associated with 
the granular pellet appears to be derived from psS]cystine 
transported into fibroblasts via the X-ca transport system. 
We have previously described two lysosomal transport sys- 
tems which recognize small neutral amino acids, lysosomal 
systems e and f (30). If psS]cysteine was being sequestered 
into fibroblast lysosomes from the cytosol by lysosomal sys- 
tems e or f, then alanine, a known substrate for these two 
Fractions after a 2- or 5-min Cellular Uptake 
[~4ClAlanine uptakes  [35S]Cystine uptakes 
2 min  5 min  2 min  5 min 
Lysate supernatants  36,259  39,715  35,010  83,083 
1,500 g supernatant  36,738  40,813  29,250  72,527 
20,000 g supernatant  33,843 (95%)  34,193 (85%)  14,535 (52%)  29,233 (43%) 
20,000 g pellet  1,741 (5%)  5,818 (15%)  13,596 (48%)  38,342 (57%) 
2  IO0-mm confluent plates of normal human fibroblasts were incubated with 3.0 ml of 0.02  mM [3SS]cystine or 0.02  mM [~4C]alanine in a Krebs-Ringer phos- 
phat~ solution, pH 7.4,  containing 2 mM aminooxyacetic acid for either 2 or 5 min at 37°C.  At the end of this time, monolayers were washed three times with 
ice-cold PBS; cells were scraped from the plate into PBS containing  10 mM NEM, and collected by centrifugation; and the cell pellet was washed once with 20 
mM MOPS/Tris (pH 7.0) buffer containing 0.275 M mannitol and 10 mM NEM. Cells were then lysed by up and down pipctting and a 20,000 g granular fraction 
prepared as described  in Materials and Methods.  The distribution  of total radioactivity (cpm) recovered from the various cell fractions is listed. 
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Figure 2. Subfractionation of the fibroblast granular fraction from 
[35S]cysteine uptakes on Percoll density gradients. Normal human 
fibroblasts  were  incubated  with  20  #M  [35S]cystine in  Krebs- 
Ringer (pH 7.4) buffer for 5 min at 37°C, the cells were then washed 
three times with ice-cold PBS, and lysed; and a granular fraction 
was prepared as described in Materials and Methods. The granular 
fraction (0.35 ml) was placed on top of 10 ml of a 34% Percoll solu- 
tion in 18 mM MOPS/Tris (pH 7.0) buffer containing 0.24 M man- 
nitol and  1 mM Na2EDTA, and centrifuged for 35 min at 17,500 
rpm in a rotor (SS-34; Sorvall Instruments  Div.) at 4°C.  0.5-ml 
fractions were collected from the bottom of the density gradient and 
assayed for hexosaminidase activity (r,) and counted for radioactiv- 
ity (e). 
transport  systems,  should  also  be  found  sequestered  into 
fibroblast lysosomes when fibroblasts are incubated with ala- 
nine.  To  test this  possibility,  human  fibroblasts  were  in- 
cubated with [t4C]alanine for 2 or 5 min and then the distri- 
bution of radioactivity among the various cell fractions was 
determined (Table I). In marked contrast to the results found 
with  [35S]cystine,  only 5-15 % of the total alanine radioac- 
tivity taken up by the  fibroblasts was associated with the 
granular pellet. Furthermore, when the granular pellet from 
the ['4C]alanine uptakes was fractionated on Percoll density 
gradients, the radioactivity associated with the granular pel- 
let did not sediment with the lysosomal marker enzyme,/3-N- 
acetyl-hexosaminidase (Fig.  4).  These results indicate that 
lysosomal transport systems e and f do not provide for any 
significant uptake of alanine into human fibroblast lysosomes 
during short uptake periods and that the process mediating 
lysosomal sequestration of cysteine does not recognize ala- 
nine and must be distinct from lysosomal transport systems 
e and f. 
Isolated fibroblast lysosomes were then examined for the 
existence  of a  transport  activity  mediating  this  apparent 
lysosomal uptake of cysteine. At pH 7.0 and 37°C,  [35S]cys- 
teine was observed to be taken up by fibroblast lysosomes in 
a linear fashion during the first 4-5 min of incubation and 
attained a steady state by 10 min (Fig. 5). DTT was included 
in the cysteine uptake incubation mixtures toprevent oxida- 
tion of cysteine to cystine. Replacing DTT by GSH had no 
effect on time courses of lysosomal cysteine uptake.  Lyso- 
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Figure  3.  Ability  of various  amino  acids,  when  added  to  the 
[35S]cystine uptake assays, to cause a decrease in the amount of 35S 
radioactivity associated with the granular fraction. Two confluent 
100-mm plates of human fibroblasts were incubated with 20 t~M 
[35S]cystine for 5 min at 37°C in Krebs-Ringer  (pH  7.4) buffer 
containing the indicated amino acid at a concentration of 10 mM. 
Incubations were terminated by washing the plates three times with 
ice-cold PBS, scraping the cells into PBS containing 10 mM NEM, 
and preparing  a granular  fraction  as described  in Materials  and 
Methods. The amount of radioactivity present within the granular 
fraction  per unit of hexosaminidase activity  was determined  for 
each amino acid listed and is given as a percent of the amount of 
35S radioactivity associated with the granular pellet per unit hexos- 
aminidase activity in control incubations not exposed to analogs. 
CM-Cysteine and CE-Cysteine, Carboxymethyl- and Carboxyethyl- 
L-Cysteine, respectively. 
somal cysteine uptake displayed a large temperature depen- 
dence, giving linear Arrhenius plots over the tested tempera- 
ture range from 17 to 37°C from which an activation energy 
of 21  kcal/mol and a  Qt0 of 3.2  were calculated  (data not 
shown). This is the highest activation energy found for any 
of the known lysosomal transport systems. 
The potential role of this system in transporting cysteine 
into the lysosomal compartment from the cytosol is reflected 
by its pH curve. Very little transport of cysteine is observed 
at the  acidic  pHs between 5  and  6  but then transport in- 
creases 7-10-fold between pH 6 and 7.5 (Fig. 6). If this pH 
dependency exists on both sides of the lysosomal membrane, 
then once cysteine is transported into the lysosome from the 
cytosol,  the  intralysosomal pH  of 5.3  (40)  would  not  be 
favorable for exodus of cysteine from the lysosome by this 
transport route, thus resulting in net lysosomal cysteine ac- 
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Figure 4.  Subfractionation  of the fibroblast  granular fraction from 
[]4C]alanine  uptakes  on Percoll density gradients.  Human fibro- 
blasts  were incubated  with  20 #M  [~4C]alanine in Krebs-Ringer 
(pH 7.4) buffer for 5 min at 37°C; the cells were then washed three 
times with ice-cold PBS, and lysed; and a granular fraction was pre- 
pared as described in Materials  and Methods. The granular (0.35- 
ml) fraction was placed on top of 10 ml of a 34% Percoll solution 
in 18 mM MOPS/Tris (pH 7.0) buffer containing 0.24 M mannitoi 
and 1 mM Na2EDCI'A,  and centrifuged for 35 min at 17,500 rpm in 
a rotor (SS-34;  Sorvall Instruments Div.) at 4°C. 0.5-ml  fractions 
were collected from the bottom of the Percoll density gradient and 
assayed for hexosaminidase  activity (zx) and counted for radioactiv- 
ity (o). 
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Figure 5.  Time course of [35S]L- 
cysteine uptake into Percoll-puri- 
fled fibroblast lysosomes. Percoll- 
purified fibroblast lysosomes were 
incubated at 37°C with 0.054 mM 
[35S]L-cysteine (1 Ci/mmol) in 20 
mM MOPS/Tris (pH 7.0) buffer 
containing 0.25 M sucrose and 1 
mM DTT.  At the indicated  time 
points, aliquots were removed from 
the incubation mixture and added to 12 ml of ice-cold PBS; lyso- 
somes  were then collected on GF/A filters,  washed  twice  with 
12-ml portions of ice-cold PBS, and the filters counted for radio- 
activity. 
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Figure 6. pH profile of 0.034 mM 
[3sS]L-cysteine uptake into fibro- 
blast lysosomes.  Fibroblast lyso- 
somes (18 #1) suspended in 0.25 
M  sucrose were  incubated  with 
18 ul of 0.068 mM [35S]L-cysteine 
in either  15 mM 4-morpholine- 
ethanesulfonic  acid (MES) or 15 
mM MOPS buffers containing 0.25 
M sucrose and 2 mM DTT which 
had been titrated  to the indicated 
pH with Tris-free  base.  Incubations were performed at 37°C for 
2.5 min at the end of which time 27-#1 aliquots  of the lysosomal 
incubations were filtered and washed, and the amount of  radioactive 
cysteine taken up was counted. MES buffer was used from pH 5-6.5 
and MOPS buffer from pH 6.5-8.5. 
cumulation. We have not determined the basis of this pH de- 
pendency of lysosomal cystein'e uptake.  The initial rate of 
lysosomal  cysteine  uptake,  however,  is  reduced  by  60% 
when uptakes are performed at pH 7.0 in the presence of ei- 
ther  15 ~M carbonyl cyanide m-chlorophenylhydrazone or 
25 #M monensin containing 75 mM NaCI. These ionophores 
would be expected to dissipate  the pH gradient across the 
lysosomal membrane. Though additional work is required in 
this regard,  it is conceivable that lysosomal cysteine trans- 
port may be driven by protons in a manner analogous to that 
described by Mancini et al. (24) for the lysosomal sialic acid 
transport  system. 
A  Michaelis-Menten  plot  (Fig.  7)  of the  initial  rate  of 
lysosomal cysteine uptake as a function of substrate concen- 
tration demonstrates that the uptake process is saturable and 
yields a linear Lineweaver-Burk plot (Fig. 7, inset). The ap- 
parent kinetic constants for lysosomal cysteine uptake at pH 
7.0 and 37°C were calculated to be Km=  53 #M  +  6  #M 
and  Vmax =  0.7  pmol  min-'  hex-'  +  0.04  using  Cleland's 
TOORGL  computer  program  (9).  A  small,  nonsaturable 
component of uptake, K~ =  0.16 pmol rain  -t hex-' mM-'  + 
0.017,  was accounted for by this computer analysis. 
Analog inhibition experiments were performed to assess 
the substrate specificity of this lysosomal cysteine transport 
system (Table II). A  high degree of specificity for cysteine 
is demonstrated by the inability of any of the amino acid ana- 
logs  at  concentrations  of  5  mM  to  significantly  inhibit 
lysosomal uptake of 0.035 mM [3sS]cysteine,  whereas 5 mM 
L-cysteine was strongly inhibitory.  Analogs very similar in 
structure to cysteine,  such as homocysteine, penicillamine, 
and serine,  demonstrated at best only a weak inhibition of 
lysosomal cysteine uptake.  Furthermore,  D-cysteine and the 
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Figure 7. Kinetics of the initial rate of  cysteine uptake into fibroblast 
lysosomes as a function of cysteine concentration. Fibroblast lyso- 
somes were incubated  for 2.5 min at 37"C with [35S]L-cysteine  of 
the indicated  concentration in 30 mM MOPS/Tris (pH 7.0) buffer 
containing 0.25 M sucrose and DTT as indicated  in Materials  and 
Methods. At the completion of the incubation period, lysosomes 
were collected and washed on GF/A filters, and the amount of radio- 
active cysteine taken up was measured.  A Michaelis-Menten plot 
of  the initial rate of  cysteine uptake as a function of  the cysteine con- 
centration  is  shown.  (Inset)  Double-reciprocal plot of the same 
data. 
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Fibroblust Lysosomes by Various Amino Acid Analogs 
Amino Acid  % of Uninhibited Rate 
L-Cysteine  6 
Cysteamine  17 
D,L-Homocysteine  80 
D-Cysteine  83 
L-Serine  84 
L-Leucine  86 
L-Penicillamine  89 
L-Valine  90 
L-Proline  97 
#-Mercaptopropionate  98 
L-Alanine  99 
Olycine  101 
L-Arginine  105 
I.-Aspartate  110 
D-Penicillamine  119 
The  uptake of 0.035  mM  135S]cysteine into fibroblast  lysosomes was mea- 
sured in the presence or absence of each of the listed amino acids each at a con- 
centration of 5 raM, except O,L-homocysteine which was at 10 raM. Uptakes 
were performed for 2.5 min at 37"C  in 30 mM MOPS/Tris  (pH 7.0) buffer 
containing 0.25  M sucrose and  15 mM DTT (except 30 mM IYlW was used 
in the case of homocysteine). At the completion of the incubation period, ali- 
quots were removed from the given incubation mixture, lysosomes were col- 
lected and washed on GF/A filters, and filters were counted for radioactivity. 
The resulting amount of radioactivity taken up per analog tested is expressed 
as a percent of the uninhibited control. 
deaminated form of cysteine,/5-mercaptopropionate,  had lit- 
tle if any effect on lysosomal [35S]cysteine uptake indicating 
that both the L-isomer and the a-amino group of cysteine are 
important for recognition by the transport protein  receptor 
site. The ot-carboxy group of cysteine, however, does not ap- 
pear to be required  for recognition  in that cysteamine was 
found to strongly inhibit lysosomal cysteine uptake. 
All of the studies reported above were repeated with lyso- 
somes  from cystinotic  fibroblasts,  in  which  case  the  time 
course  of lysosomal  cysteine  uptake,  Arrhenius  plot,  pH 
curve,  and  substrate  specificity were very similar to those 
found with lysosomes from normal human fibroblasts. Two 
small differences,  however, were detected  in the lysosomal 
cysteine transport activity of the cystinotic fibroblast cell line 
which was compared with the normal fibroblast cell line: (a) 
a Km of 0.1  mM was found for lysosomal cysteine uptake by 
cystinotic  lysosomes  compared  with  0.05  mM  in  normal 
lysosomes, and (b) lysosomal cysteine uptake was stimulated 
twofold when 4.5 mM MgATP was added to incubation mix- 
tures of cystinotic  lysosomes,  whereas  no stimulation  was 
observed with normal fibroblast lysosomes. 
Mannitol  is a  membrane-impermeant marker which  ac- 
cumulates  in  the  lysosomal  compartment  as  a  result  of 
pinocytosis, and is lost via exocytosis (22,  26).  The rate of 
mannitol  loss  from  cystinotic  fibroblasts  is  the  same  (t,/2 
17 h) whether cells are incubated in cystine-free or cystine- 
containing  culture  medium  (Fig.  8  A).  When  cystinotic 
fibroblasts  are  prelabeled  with  [35S]cystine  for 24  h,  free 
[35S]cystine  accumulates  intracellularly  and  is  exclusively 
localized  within  the  lysosomal  compartment  (27,  36,  38). 
Upon  being  washed  and  placed  in  cystine-free  culture 
medium, cystinotic fibroblasts lose [3~S]cystine  at the same 
slow rate observed for lysosomal loss of [3H]mannitol;  i.e., 
at the  exocytosis rate.  When  0.1  mM  unlabeled  cystine  is 
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Figure 8.  Loss  of [35S]eystine or  [3H]mannitol  from  cystinotic 
fibroblasts in cystine-containing vs. eystine-deficient culture media. 
(A) Confluent 60-mm plates of cystinotic fibroblasts were incubated 
for 24 h in 3 ml of cystine-deficient culture media supplemented 
with 10% dialyzed FCS containing either [3H]mannitol  (2.2 x  106 
cpm/ml;  19  Ci/mmol)  or  [3SS]eystine (1.9  x  106 cpm/ml; 460 
Ci/mmol). The plates were then washed three times with PBS and 
at time zero exposed to culture media deficient in cystine (-cys) 
or exposed to culture media containing 0.133 mM cystine (+ cys). 
At the times of 0, 4, 8, and 24 h, individual plates were harvested 
and the amount of [3~S]cystine or [3H]mannitol  radioactivity as- 
sociated with the cells at these different time points is given as a 
percent of the time zero (To) cell-associated radioactivity: loss of 
[35S]cystine from flbroblasts in cystine-containing (-) and cystine- 
deficient  media  (t~); loss  of  [3H]mannitol  from  fibroblasts  in 
cystine-containing (A) and cystine-deficient  culture media (zx). (B) 
Cystinotic fibroblasts were labeled for 24 h with [35S]cystine (1  x 
106 cpm/ml; 682 Ci/nmol) as described above, washed three times 
with PBS, and at time zero exposed to cystine-deficient  culture me- 
dia  supplemented  with  either  0.1  mM  cystathionine,  0.1  mM 
homocystine, 0.1 mM cystine, or no further addition. At the times 
of 0, 4, 8, and 24 h, individual plates were harvested and the amount 
of [35S]cystine recovered  from the  cells  at  these  different time 
points  is given:  loss of [35S]cystine from fibroblasts exposed to 
cystine-deficient  culture media only (e), or this same media sup- 
plemented  with  either  0.1  mM  cystathionine  (zx), 0.1  mM 
homocystine (t2), or 0.1  mM cystine (l). 
added to the culture medium, however, 85 % of the intracel- 
lular  ['S]cystine  is lost within  the first 4  h  of incubation. 
Although  a  rapid  loss  of  intracellular  [a~S]cystine  is  ob- 
served when cystinotic fibroblasts are incubated  in cystine- 
containing  culture  medium,  there  is  no  loss  in  the  total 
amount of intracellular free cystine indicating  that this loss 
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The basis for this exchange reaction is now apparent.  When 
unlabeled cystine is transported into the cytosol it is reduced 
by GSH to form cysteine which then enters the lysosome by 
the cysteine-specific lysosomal transport system. Once with- 
in the lysosome, unlabeled cysteine exchanges with psS]cys- 
tine  to  form unlabeled cystine and  [35S]cysteine,  with  this 
latter  product  egressing  from the  lysosome by one of the 
transport routes capable of recognizing cysteine. In contrast 
to cystine, the analogs homocystine and cystathionine do not 
accelerate [3sS]cystine loss from cystinotic fibroblasts (Fig. 
8 B). Upon entering the cytosol, homocystine would be ex- 
pected to form homocysteine when reduced by GSH. Homo- 
cysteine, however, is not recognized by the cysteine-specific 
lysosomal transport system (Table II) and as a consequence 
homocysteine would not be able to enter lysosomes and ex- 
change with [35S]cystine. The net result is that homocystine 
added to cystine-free culture medium  has  no effect on the 
loss  of lysosomal  [3~S]cystine, from  cystinotic  fibroblasts. 
Although we find that cystathionine is transported into fibro- 
blasts at a rate similar to that for cystine (data not shown), 
it can not be reduced by GSH and is not able to participate 
in disulfide/sulfhydryl exchange reactions with cystine. 
Discussion 
The lysosome contains a large repertoire of enzymatic activi- 
ties which function optimally at the acidic environment of 
this organelle to degrade a wide variety of macromolecules. 
Over the course of the last  10 years, various investigations 
have pointed to the role of thiol  in  stimulating  the rate of 
lysosomal degradation  of disulfide-rich  proteins.  In  1979, 
Griffiths and Lloyd (17) observed an enhanced  rate of ~2q_ 
insulin degradation by disrupted rat liver lysosomes when re- 
duced glutathione was added to incubation mixtures.  Later, 
Kooistra et al.  (21) found that a variety of thiols were able 
to stimulate  the rate at which purified  lysosomal enzymes 
could degrade  ~25I-labeled insulin  or albumin.  Among  the 
lysosomal enzymes studied was cathepsin D, which is not a 
thiol-dependent  enzyme.  These authors  postulated that the 
two processes of proteolysis and disulfide reduction act syn- 
ergistically  to facilitate lysosomal degradation  of proteins. 
First, thiols activate the thiol-dependent lysosomal enzymes 
(e.g.,  cathepsins B, H,  and L); and,  second, thiols reduce 
protein disulfide linkages allowing proteins to unfold, there- 
by  providing  proteinases  access  to  susceptible  linkages 
within the substrate. Subsequently, Mego (25) demonstrated 
that cysteine accelerated the rate of intralysosomal proteoly- 
sis of the disulfide-rich protein BSA in intact mouse kidney 
lysosomes.  Cysteine did  not  increase  the  rate  of albumin 
breakdown, however, when the disulfide bonds of albumin 
had been previously reduced and alkylated,  providing fur- 
ther evidence that thiols function to facilitate proteolysis of 
disulfide-rich proteins by reducing their disulfide linkages. 
In addition,  Shen et al. (39) have found that the cytotoxicity 
of a  conjugate  in which  methotrexate  is linked  to poly(D- 
lysine) through a disulfide spacer is dependent upon reduc- 
tion of the disulfide linkage and that this reductive step likely 
occurs in either a prelysosomal or lysosomal compartment. 
In a review of the above studies concerning disulfide reduc- 
tion in lysosomes, Lloyd (23) postulated that cysteine from 
the cytoplasm may be the physiological agent responsible for 
the intralysosomal  reduction of proteiff disulfides. 
Our present  investigation demonstrates  that a  lysosomal 
transport system, highly specific for cysteine, provides a ma- 
jor route for the delivery of cysteine to the lysosomal com- 
partment. The ability of this route to sequester large amounts 
of cysteine into lysosomes is evident from the cystine uptake 
studies demonstrating that a minimum of 50-60% of the total 
[35S]cystine radioactivity taken up into cystinotic or normal 
fibroblasts is sequestered as cysteine into lysosomes (Table 
I), which comprise only 4% of the intracellular  volume of 
normal human fibroblasts and  10%  of the intracellular  vol- 
ume of cystinotic fibroblasts (11). This large degree of lyso- 
somal cysteine sequestration occurs rapidly, being observed 
within the first 2  min of incubating  intact fibroblasts with 
[35S]cystine. Further evidence of the ability of this transport 
system to deliver cysteine to the lysosomal compartment  is 
indicated  by the 35S chase experiments  demonstrating  that 
the  addition  of unlabeled  cystine  to  culture  medium  pro- 
duces an accelerated loss of intracellular  [3~S]cystine from 
cystinotic fibroblasts whereas homocystine is without effect 
(Fig.  8 B). 
The interchange between cystine and cysteine within the 
fibroblast appears to be a cyclic process, designed to address 
the  requirements  for  cellular  metabolism  within  both  the 
cytosolic and lysosomal compartments (see Fig. 9). Cystine 
is transported across the plasma membrane into the cytosol 
by  the  X-co  transport  system  (3-5).  Upon  entering  the 
cytosol, cystine is reduced by GSH to form cysteine and the 
mixed disulfide of glutathione  and cysteine.  Although  low 
levels of this latter product have been observed in fibroblasts 
(3, 37), the majority of the mixed disulfide of glutathione and 
cysteine appears to be metabolized to other cellular constitu- 
Figure 9. Schematic diagram showing (a) the interconversions be- 
tween cystine and cysteine in different cellular compartments, (b) 
the role of transport systems in maintaining this cycle, and (c) the 
role of cysteine in supporting lysosomal proteolysis. Shaded area 
represents  the  cytosol  whereas  the  clear  area  represents  the 
lysosomal compartment; ASC, L, asc, and X-co are plasma mem- 
brane amino acid transport systems. 
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rat  liver and bovine kidney extracts  (7,  12,  46).  Cysteine 
formed in the cytosol can be transported back into the ex- 
traceUular space where it is reoxidized to form cystine (2). 
Cytosolic  cysteine can  also  be used  for  the  synthesis  of 
gluthathione and proteins, metabolized for the production of 
other cellular constituents,  or, as we have now shown,  se- 
questered into the lysosomal compartment by the cysteine- 
specific lysosomal transport system to aid lysosomal proteol- 
ysis. Once within the lysosomal compartment, cysteine can 
react with protein disulfide bridges,  as suggested by Lloyd 
(23), leading first to the formation of equimolar amounts of 
protein-linked cysteine and cystine at the site of each original 
disulfide bridge, and, after proteolysis, released into the ly- 
sosome as free cystine and cysteine. This cystine formed in 
the lysosome is then transported out of the lysosome into the 
cytosol by the lysosomal cystine transport system known to 
be defective in nephropathic cystinosis.  Upon reaching the 
cytosol, cystine is reduced back to cysteine by GSH. No net 
production  of intralysosomal  cystine from cysteine occurs 
via this mechanism. This model accounts for the observation 
of Thoene and co-workers (42, 43, 45) that cystinotic fibro- 
blasts accumulate lysosomal cystine from the degradation of 
disulfide-rich proteins but not from degrading cysteine-rich 
proteins. 
We now see that the lysosomal membrane contains  two 
highly specific transport systems involved in regulating the 
flow of cystine and cysteine between the intralysosomal space 
and the cytosol. Especially striking is how these two trans- 
port systems have adapted their properties to use the differ- 
ences in pH and reducing environment, which exist between 
the cytosolic and lysosomal compartments,  to direct their 
flow of substrate.  (a) The pH dependence of the cysteine- 
specific lysosomal transport  system appears  to be used in 
conjunction with the difference in pH between the cytosol 
and intralysosomal space so as to direct net cysteine flow into 
lysosomes from the cytosol. We have not elucidated the basis 
of this pH dependence but our initial results with protono- 
phores suggest that lysosomal cysteine transport may be cou- 
pled to the movement of protons or other ions across the 
lysosomal membrane.  (b) At the neutral pH of the cytosol 
and extracellular  medium,  two ionic forms of cystine pre- 
dominate: the zwitterionic, tetrapolar form and the anionic, 
tripolar form. It is this latter, anionic form of cystine, which 
is recognized by the plasma membrane X-cG transport sys- 
tem  (4,  5).  In  contrast,  within  the  acidic  milieu  of the 
lysosomal interior only the zwitterionic,  tetrapolar form of 
cystine predominates and accordingly the specificity of the 
lysosomal cystine transport system appears to be directed to- 
wards this tetrapolar form of cystine (15), thus allowing it to 
function in accordance with the restrictions imposed by the 
acidic environment of the intralysosomal space. The net flow 
of lysosomal cystine transport  is essentially unidirectional 
outward as a consequence of the reducing environment of the 
cytosol and the lysosome/cytosol pH gradient. 
The manner by which cysteine is able to egress from lyso- 
somes remains to be determined. Lysosomal cysteine exodus 
could be facilitated by lysosomal systems e and f, which both 
recognize a broad range of small neutral amino acids.  For 
the present time, we have shown these two transport systems 
as being likely candidates for mediating lysosomal cysteine 
exodus in Fig. 9. The lysosomal cysteine-specific transport 
system is the first transport system to be described which ap- 
pears to function for the net delivery of its substrate into the 
lysosomal compartment.  Rome and co-workers (1, 34) how- 
ever,  have  characterized  a  lysosomal  membrane  enzyme, 
acetyl-CoA  (t~-glucosaminide  N-acetyltransferase),  which 
catalyzes the transfer of the acetyl group of cytosolic acetyl- 
CoA to terminal a-linked glucosamine residues of heparan 
sulfate within the lysosome. 
In 1976, Thoene et al. (44) demonstrated depletion of cys- 
tine from nephropathic cystinotic cells by treatment with cys- 
tearnine  which  reacts  with  intralysosomal  cystine to  form 
cysteine and the mixed disulfide of cysteamine and cysteine. 
Subsequently, we showed that the mixed disulfide of cyste- 
amine  and  cysteine is  recognized  by  lysosomal  system c 
which serves for removal of this mixed disulfide from the 
lysosome (29, 31). The manner by which cysteamine is able 
to enter lysosomes, however, has not been determined.  Our 
analog inhibition analysis (Table II) indicates that cysteamine 
is recognized by the lysosomal cysteine transport system by 
virtue of its ability to strongly inhibit  [35S]cysteine uptake, 
but whether cysteamine is actually transported by this route 
remains to be determined. Thus, these studies provide a fo- 
cus for future investigations  to determine if the lysosomal 
cysteine-specific transport system plays an important role in 
the delivery of cysteamine to the lysosomal compartment and 
allow for a more complete understanding of the basis of cys- 
teamine therapy in the treatment of cystinosis. 
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